MOLECULAR PARTNERS AG Interest Expense Defined Benefit Plans
MOLECULAR PARTNERS AG (MOLN) reported Interest Expense Defined Benefit Plans of CHF 659.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpenseDefinedBenefitPlans · last filed 2026-03-12
| Period end | Interest Expense Defined Benefit Plans 12 month |
|---|---|
| 2025-12-31 | 659.00K CHF 20-F · filed 2026-03-12 |
| 2024-12-31 | 836.00K CHF 20-F · filed 2026-03-12 |
| 2023-12-31 | 1.18M CHF 20-F · filed 2026-03-12 |
| 2022-12-31 | 231.00K CHF 20-F · filed 2025-03-06 |
| 2021-12-31 | 114.00K CHF 20-F · filed 2024-03-14 |
| 2020-12-31 | 103.00K CHF 20-F · filed 2023-03-09 |
| 2019-12-31 | 356.00K CHF 20-F · filed 2022-03-15 |